Travel Medicine Update

Icahn School of Medicine at Mount Sinai

D. Caplivski

Nirsevimab for RSV: A Breakthrough Product for Babies

MicrobeTV

P. Offit, V. Racaniello

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

COVID 2024 Surge: The Most Accessible Defense

MedCram

R. Seheult

Preparing for Winter: CDC Recommendations for Influenza, COVID-19, a…

Diego Hijano

What's New with COVID in 2024?

Michigan Medicine

L. Washer

The Durability of the Antibody Response Following Monkeypox Vaccinat…

MicrobeTV

D. Griffin, V. Racaniello

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

EADV 2023 Insights

G. Hofbauer

Emergency Use Authorization for Updated COVID Vaccine, West Nile Vir…

MicrobeTV

D. Griffin, V. Racaniello

Newly Licensed Respiratory Syncytial Virus Vaccines for Adults: What…

MicrobeTV

P. Offit, V. Racaniello

Vaccines for Adults: COVID, RSV, Influenza and More

Michigan Medicine

L. Washer

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

Mpox Circulation and New Vaccine Approval, Largest Outbreak of Whoop…

MicrobeTV

D. Griffin, V. Racaniello

Project 2025 vs. The Public’s Health: What is Project 2025? What is …

MicrobeTV

P. Offit, V. Racaniello

Vaccination vs. Antiviral Therapy Against Mpox, Authorization and Ap…

MicrobeTV

D. Griffin, V. Racaniello

September 2024 Public Health Infectious Disease Updates

California Medical Association

E. Pan

Update on Adult Immunizations (July 2024): Part 1

Barbara Yawn

CDC Guidelines for Seasonal Influenza Vaccines, How and When to Use …

MicrobeTV

D. Griffin, V. Racaniello

Recent ACIP Recommendations for RSV Vaccines for Patients Over 60, T…

MicrobeTV

D. Griffin, V. Racaniello

Restoring Faith in Vaccines

MicrobeTV

P. Offit, V. Racaniello